Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles

Ali Nokhodchi, El Larhrib

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier
LanguageEnglish
Pages879-882
Number of pages4
JournalTherapeutic Delivery
Volume4
Issue number8
DOIs
Publication statusPublished - 2013

Fingerprint

Dry Powder Inhalers
Mannitol

Cite this

@article{6564b090dacd4e9db2c4363bc3832658,
title = "Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles",
abstract = "Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier",
keywords = "aerosolization performance, dry-powder inhaler, lactose, mannitol, particle engineering",
author = "Ali Nokhodchi and El Larhrib",
year = "2013",
doi = "10.4155/tde.13.64",
language = "English",
volume = "4",
pages = "879--882",
journal = "Therapeutic Delivery",
issn = "2041-5990",
publisher = "Future Science",
number = "8",

}

Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles. / Nokhodchi, Ali; Larhrib, El.

In: Therapeutic Delivery, Vol. 4, No. 8, 2013, p. 879-882.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Overcoming the undesirable properties of dry-powder inhalers with novel engineered mannitol particles

AU - Nokhodchi, Ali

AU - Larhrib, El

PY - 2013

Y1 - 2013

N2 - Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier

AB - Designing an ideal carrier for dry-powder inhaler formulation is still a challenge as there is no absolute conclusion on the ideal physicochemical properties, micromeritics and morphology for a carrier

KW - aerosolization performance

KW - dry-powder inhaler

KW - lactose

KW - mannitol

KW - particle engineering

U2 - 10.4155/tde.13.64

DO - 10.4155/tde.13.64

M3 - Article

VL - 4

SP - 879

EP - 882

JO - Therapeutic Delivery

T2 - Therapeutic Delivery

JF - Therapeutic Delivery

SN - 2041-5990

IS - 8

ER -